REAP Financial Group’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

REAP Financial Group’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$192K	Sell	954 -23	-2%	-$4.76K	0.04%	133
2025 Q4	$202K	Sell	977 -136	-12%	-$27.2K	0.04%	126
2025 Q3	$200K	Buy	1,113 +133	+14%	+$22.6K	0.04%	113
2025 Q2	$158K	Hold	980	–	–	0.04%	132
2025 Q1	$167K	Hold	980	–	–	0.04%	110
2024 Q4	$163K	Buy	980 +400	+69%	+$68.3K	0.04%	123
2024 Q3	$99.7K	Sell	580 -379	-40%	-$62.7K	0.02%	159
2024 Q2	$148K	Sell	959 -442	-32%	-$66.3K	0.04%	135
2024 Q1	$215K	Sell	1,401 -21	-1%	-$3.2K	0.06%	120
2023 Q4	$225K	Buy	+1,422	New	+$204K	0.07%	126

Other funds holding FBT

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return

REAP Financial Group's FBT Position: Q1 2026 in Review

REAP Financial Group reduced its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 2.4% in Q1 2026, selling an estimated $4.76K and leaving 954 shares worth $192K. The position accounts for 0.04% of the portfolio, ranked #133.

REAP Financial Group first reported a position in FBT in Q4 2023 and has held it in 10 quarters since. The position peaked at $225K in Q4 2023. 307 funds tracked by Wall St. Rank hold FBT as of Q1 2026.

REAP Financial Group held 954 shares of First Trust NYSE Arca Biotechnology Index Fund worth $192K as of Q1 2026.
REAP Financial Group sold 23 First Trust NYSE Arca Biotechnology Index Fund shares in Q1 2026, an estimated $4.76K.
First Trust NYSE Arca Biotechnology Index Fund made up 0.04% of REAP Financial Group's portfolio in Q1 2026, its #133 holding.
REAP Financial Group first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2023 and has held it in 10 quarters since.
REAP Financial Group's First Trust NYSE Arca Biotechnology Index Fund position peaked at $225K in Q4 2023.
307 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2026.

Based on REAP Financial Group's 13F filing for Q1 2026, filed 11 May 2026.